Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 7, 2013
Previous Article Next Article

Predicting cancer drug mechanisms of action using molecular network signatures

Author affiliations

Abstract

Molecular signatures are a powerful approach to characterize novel small molecules and derivatized small molecule libraries. While new experimental techniques are being developed in diverse model systems, informatics approaches lag behind these exciting advances. We propose an analysis pipeline for signature based drug annotation. We develop an integrated strategy, utilizing supervised and unsupervised learning methodologies that are bridged by network based statistics. Using this approach we can: 1, predict new examples of drug mechanisms that we trained our model upon; 2, identify “New” mechanisms of action that do not belong to drug categories that our model was trained upon; and 3, update our training sets with these “New” mechanisms and accurately predict entirely distinct examples from these new categories. Thus, not only does our strategy provide statistical generalization but it also offers biological generalization. Additionally, we show that our approach is applicable to diverse types of data, and that distinct biological mechanisms characterize its resolution of categories across different data types. As particular examples, we find that our predictive resolution of drug mechanisms from mRNA expression studies relies upon the analog measurement of a cell stress-related transcriptional rheostat along with a transcriptional representation of cell cycle state; whereas, in contrast, drug mechanism resolution from functional RNAi studies rely upon more dichotomous (e.g., either enhances or inhibits) association with cell death states. We believe that our approach can facilitate molecular signature-based drug mechanism understanding from different technology platforms and across diverse biological phenomena.

Graphical abstract: Predicting cancer drug mechanisms of action using molecular network signatures

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 19 Oct 2012, accepted on 19 Dec 2012 and first published on 20 Dec 2012


Article type: Paper
DOI: 10.1039/C2MB25459J
Citation: Mol. BioSyst., 2013,9, 1604-1619
  •   Request permissions

    Predicting cancer drug mechanisms of action using molecular network signatures

    J. R. Pritchard, P. M. Bruno, M. T. Hemann and D. A. Lauffenburger, Mol. BioSyst., 2013, 9, 1604
    DOI: 10.1039/C2MB25459J

Search articles by author